VOR
VOR
NASDAQ · Biotechnology

Vor Biopharma Inc

$13.16
+1.09 (+9.03%)
As of Feb 8, 2:00 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 9 82%
Hold 2 18%
Sell 0 0%
Price Target
Analyst Price Target +164.0% upside
Low Target $25.90
Average Target $34.74
High Target $38.60
Current Price $13.16
Current
$13.16
Target
$34.74
$25.90 $34.74 avg $38.60
Scenario Analysis
Bear Case
$25.90
96.8%
Low target
Base Case
$34.74
+164.0%
Avg target
Bull Case
$38.60
+193.3%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$29.91
-56.0% from high
52-Week Low
$24.38
+-46.0% from low
Target vs 52W High
$34.74
+16.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%